Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia: a Randomized, Double-Blind, Placebo Control Trial

NCT06764329 is registered in ClinicalTrials.gov with National Institute of Blood and Marrow Transplant (NIBMT), Pakistan as lead sponsor.

NCT NCT06764329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06764329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia: a Randomized, Double-Blind, Placebo Control Trial
Lead sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
December 25, 2024
Completion date
August 30, 2025
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, androgenetic alopecia (aga)